Medicine guide
Tyenne
400 mg/20mL · Injection, Solution, Concentrate
- Prescription only
- Interleukin-6 Receptor Antagonist
- Active substance
- Tocilizumab-Aazg
- Made by
- Fresenius Kabi USA, LLC
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupCancer treatments and immune-system medicines
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Fresenius Kabi USA, LLC |
|---|---|
| Active substance | Tocilizumab-Aazg |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 400 mg/20mL |
| Form | Injection, Solution, Concentrate |
| Route | Intravenous |
| Packs | 1 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE |
| NDC | 65219-594 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Injection, Solution, Concentrate3 products
- 80 mg/4mL
- 200 mg/10mL
- 400 mg/20mL
- Injection, Solution1 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.